IP Library Patent Application 16326246
Patent Application
App. No. 16/326,246

AN IMPLANT FOR REPAIR OF BONE DEFECTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/326,246
Abstract

An implant for repairing a segmental defect in a subject's bone at a segmental defect site, the implant comprising a scaffold for implantation at the segmental defect site and the implant optionally comprising: a plate for internal fixation, the plate being attachable to or integral with the scaffold, and the plate having means for securing it to bone outside of the segmental defect site; a hollow cavity within the scaffold; a plurality of longitudinal channels within the scaffold; and or a membrane received around the scaffold.

Claims (30)

1 . An implant for repairing a segmental defect in a subject's bone at a segmental defect site, the implant comprising:

a scaffold for implantation at the segmental defect site, the scaffold comprising a body, the body having a first end and a second end, the first and second ends being first and second open ends respectively, the scaffold further comprising a cavity extending between said first and second open ends.

2 . An implant according to claim 1 , wherein said first and second ends of the scaffold are opposing ends.

3 . An implant according to claim 1 , wherein each of said first and second open ends of the scaffold is configured to engage bone at the segmental defect site when implanted.

4 . An implant according to claim 1 , wherein each of said first and second open ends of the scaffold is configured to abut bone at the segmental defect site when implanted.

5 . An implant according to claim 1 , wherein the length of the scaffold between its first and second ends is selected such that the first end of the scaffold abuts bone at one side of the segmental defect site and the second end of the scaffold abuts bone at the other side of the segmental defect site when implanted.

6 . An implant according to claim 1 , wherein the implant is configured for implantation at a segmental defect site in a subject's long bone.

7 . An implant according to claim 6 , wherein the cavity in the scaffold has a longitudinal axis, the implant being configured such that the longitudinal axis of the cavity substantially aligns with a longitudinal axis of the subject's long bone at the defect site when implanted in said long bone.

8 . An implant according to claim 6 , wherein the cavity is configured to align with the medullary cavity of said long bone when implanted.

9 . An implant according to claim 6 , wherein the cross-sectional size of the cavity is selected to substantially correspond with the cross-sectional size of the medullary cavity of said long bone when implanted.

10 . An implant according to claim 6 , wherein the cross-sectional size of the scaffold is selected to substantially correspond with the cross-sectional size of said long bone.

11 .- 17 . (canceled)

18 . An implant according to claim 1 , wherein the scaffold further comprises a plurality of channels within its body, the plurality of channels being substantially aligned with a longitudinal axis of the scaffold.

19 . (canceled)

20 . An implant according to claim 18 , wherein the scaffold is porous and the plurality of channels are formed by interconnected pores in the porous structure.

21 .- 25 . (canceled)

26 . An implant according to claim 1 , wherein the scaffold is configured such that it has a first Young's modulus value in a direction of its longitudinal axis and a second Young's modulus value in a direction transverse to the longitudinal axis, the first and second Young's modulus values being different.

27 . (canceled)

28 . An implant according to claim 32 , the membrane comprising:

collagen and

a resorbable polymer selected from: poly lactic acid (PLA); poly glycolic acid (PGA);

poly lactic-co-glycolide (PLGA); polycaprolactone (PCL); and chitosan.

29 . An implant according to claim 28 , wherein the membrane has a first side for facing the scaffold when assembled and a second side for facing away from the scaffold when assembled, wherein the first side of the membrane is seeded with cells, preferably bone-forming cells selected from the group consisting of osteocytes, osteoblasts, osteoblast progenitor cells and stem cells.

30 . An implant according to claim 28 , wherein the membrane has a first side for facing the scaffold when assembled and a second side for facing away from the scaffold when assembled, wherein the second side of the membrane is seeded with cells.

31 . An implant according to claim 28 , wherein the membrane incorporates antibiotics and/or bactericidal compounds.

32 . An implant according to claim 1 , the implant further comprising a resorbable membrane received around the scaffold of the implant.

33 . (canceled)

34 . An implant according to claim 1 , wherein the scaffold is porous.

35 . An implant according to claim 1 , wherein the scaffold is made of titanium mesh.

36 .- 41 . (canceled)

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2019
From: FITZPATRICK, NOEL; MESWANIA, JAYANTILAL; BLUNN, GORDON
To: FITZBIONICS LIMITED
Reel/Frame 048800/0205 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2019
From: CLAUBERG, BERND; ZHENG, SANBAO; MISDOM, JOHANNES ADRIANUS CORNELIS
To: PHILIPS LIGHTING HOLDING B.V.
Reel/Frame 048359/0418 →